These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 15194655)
1. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Donati G; Stagni B; Piscaglia F; Venturoli N; Morselli-Labate AM; Rasciti L; Bolondi L Gut; 2004 Jul; 53(7):1020-3. PubMed ID: 15194655 [TBL] [Abstract][Full Text] [Related]
2. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371 [TBL] [Abstract][Full Text] [Related]
3. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. Huang SC; Yang YJ J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378 [TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061 [TBL] [Abstract][Full Text] [Related]
5. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347 [TBL] [Abstract][Full Text] [Related]
6. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331 [TBL] [Abstract][Full Text] [Related]
7. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. Lee YS; Kek BL; Poh LK; Saw SM; Loke KY J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869 [TBL] [Abstract][Full Text] [Related]
8. Association of nonalcoholic fatty liver disease with insulin resistance. Marchesini G; Brizi M; Morselli-Labate AM; Bianchi G; Bugianesi E; McCullough AJ; Forlani G; Melchionda N Am J Med; 1999 Nov; 107(5):450-5. PubMed ID: 10569299 [TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092 [TBL] [Abstract][Full Text] [Related]
10. Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies. Bonnet F; Gastaldelli A; Pihan-Le Bars F; Natali A; Roussel R; Petrie J; Tichet J; Marre M; Fromenty B; Balkau B; J Hypertens; 2017 Mar; 35(3):493-500. PubMed ID: 27984413 [TBL] [Abstract][Full Text] [Related]
11. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease. Manco M; Giordano U; Turchetta A; Fruhwirth R; Ancinelli M; Marcellini M; Nobili V Acta Diabetol; 2009 Jun; 46(2):97-104. PubMed ID: 18839055 [TBL] [Abstract][Full Text] [Related]
15. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833 [TBL] [Abstract][Full Text] [Related]
16. Clinical implications of controlled attenuation parameter in a health check-up cohort. Kwak MS; Chung GE; Yang JI; Yim JY; Chung SJ; Jung SY; Kim JS Liver Int; 2018 May; 38(5):915-923. PubMed ID: 28940824 [TBL] [Abstract][Full Text] [Related]
17. Factors related to non-alcoholic fatty liver disease in obese children. Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Suomela E; Oikonen M; Virtanen J; Parkkola R; Jokinen E; Laitinen T; Hutri-Kähönen N; Kähönen M; Lehtimäki T; Taittonen L; Tossavainen P; Jula A; Loo BM; Mikkilä V; Younossi Z; Viikari JS; Juonala M; Raitakari OT Ann Med; 2015 Feb; 47(1):40-6. PubMed ID: 25333756 [TBL] [Abstract][Full Text] [Related]
19. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253 [TBL] [Abstract][Full Text] [Related]
20. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]